文献速递自身炎症与 IgG4 相关病

成人Still病复发特征及危险因素:长期队列研究

Characteristics and risk factors of relapses in patients with adult-onset Still's disease: a long-term cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究纳入122例成人Still病(AOSD)患者,中位随访12.6个月,26例(21.3%)至少复发一次,6、12、18、36个月累积复发率分别为14.42%、21.79%、24.81%、28.57%。多因素分析显示强化治疗(OR 6.848,95%CI 2.441~19.211)和巨噬细胞活化综合征(OR 4.020,95%CI 1.564~10.322)与复发风险升高相关。

要点

  • AOSD患者至少五分之一出现复发,36个月累积复发率达28.57%。
  • 强化治疗与巨噬细胞活化综合征是复发的独立危险因素。
  • 初发高疾病严重度者需更强化治疗和密切随访。

核心结论

  • AOSD患者复发率至少为五分之一,初发时高疾病严重度可能增加复发风险。
  • 强化治疗和巨噬细胞活化综合征与复发风险升高独立相关。

研究设计与样本

  • 单中心长期队列研究,纳入2016年8月至2019年9月瑞金医院风湿免疫科收治的122例AOSD患者,中位随访12.6个月。
  • 采用Kaplan-Meier曲线和log rank检验估计累积复发概率和持续缓解率,多因素Cox比例风险模型识别复发危险因素。

主要发现

  • 26例(21.3%)患者至少复发一次。
  • 6、12、18、36个月累积复发率分别为14.42%、21.79%、24.81%、28.57%。
  • 多因素分析显示强化治疗(OR 6.848,95%CI 2.441~19.211)与复发风险升高相关。
  • 巨噬细胞活化综合征(OR 4.020,95%CI 1.564~10.322)与复发风险升高相关。

临床怎么用

  • 对初发高疾病严重度AOSD患者应给予更强化治疗并密切随访。
  • 合并巨噬细胞活化综合征或需强化治疗者应警惕复发风险。

局限性

  • 单中心研究,样本量有限,中位随访时间较短,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the detailed characteristics and explore the potential risk factors of relapses in patients with adult-onset Still's disease (AOSD). METHODS: We enrolled patients with AOSD admitted to the Department of Rheumatology and Immunology, Ruijin Hospital from August 2016 to September 2019. Kaplan-Meier curves and the log rank test were used to estimate the cumulative relapse probability and persistent remission rate before the first occurrence of relapse. The multivariate Cox proportional hazard method was utilized to identify risk factors associated with relapses of AOSD. RESULTS: A total of 122 patients with AOSD were enrolled with a median follow-up of 12.6 months. Among them, 26 (21.3%) patients had at least one relapse. The cumulative relapse rates of AOSD patients were 14.42%, 21.79%, 24.81% and 28.57% at 6, 12, 18 and 36 months, respectively. According to the multivariate analysis, intensive treatment (odds ratio: 6.848; 95% CI: 2.441, 19.211) and macrophage activation syndrome (odds ratio: 4.020, 95% CI: 1.564, 10.322) were associated with increased risk of relapse. CONCLUSION: Our study indicated that relapses occurred in at least one-fifth of patients with AOSD, and patients with high disease severity at initial attack may have an increased risk of relapse, which needs more intensive therapy and close follow-up.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Meng J, Chi H, Wang Z, et al. Characteristics and risk factors of relapses in patients with adult-onset Still's disease: a long-term cohort study. Rheumatology (Oxford). 2021. PMID: 33493278. doi:10.1093/rheumatology/keab023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。